Gemini has officially launched XRP perpetual contracts for traders in the European Union, introducing leverage of up to 100x, a major step in the exchange’s ongoing expansion into the European derivatives market.
The new product, announced today, marks the first time the U.S.-based crypto exchange has offered a leveraged XRP instrument to its EU clients, signaling growing institutional demand for high-liquidity altcoin exposure in a regulated framework.
XRP Futures with Institutional Precision
Gemini’s XRP perpetual contracts allow traders to take long or short positions on the token’s price without holding the underlying asset.
All profits, losses, and settlements are denominated in USDC, ensuring a stable, dollar-pegged accounting standard across trades.
The contracts are issued through Gemini Intergalactic EU Artemis, Ltd., a Malta-registered subsidiary regulated by the Malta Financial Services Authority (MFSA), giving the product a strong compliance foundation within EU financial law.
Unlike traditional futures, perpetual contracts have no expiration date, meaning positions can be held indefinitely as long as traders meet margin requirements.
Part of a Larger European Push
The addition of XRP follows the exchange’s rollout of similar perpetual products for Bitcoin, Ethereum, and Solana, reflecting Gemini’s push to capture growing derivatives demand across Europe.
The move comes as European regulators finalize MiCA implementation, giving licensed exchanges like Gemini an advantage in offering structured crypto products while maintaining transparency and investor protection.
Expanding Institutional Liquidity
With XRP’s rising prominence following its regained legal clarity in the U.S. and increasing adoption in Asia, Gemini’s launch aligns with a broader trend of derivatives-driven liquidity growth in altcoin markets.
By introducing 100x leveraged XRP trading, Gemini positions itself as one of the few Western exchanges giving institutional and advanced retail traders access to high-leverage, regulation-backed XRP derivatives in the EU.